Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, and the securities litigation firm of Powers Taylor, LLP announce that the firms are investigating legal claims against the officers and Board of Directors of ZELTIQ Aesthetics, Inc. ( NASDAQ: ZLTQ) related to potential securities violations by ZELTIQ.
If you are an affected investor and you want to learn more about the lawsuit or join the action, contact Patrick Powers at Powers Taylor, LLP, toll free (877) 728-9607, via e-mail at firstname.lastname@example.org, or Willie Briscoe at The Briscoe Law Firm, PLLC, (214) 706-9314, or via email at WBriscoe@TheBriscoeLawFirm.com. There is no cost or fee to you.
“Recent revelations have indicated that officers and directors at ZELTIQ may have issued materially false and misleading statements to investors that were designed to deceive the market and artificially inflate the company's stock price. In particular, our firms are examining allegations that senior officials at ZELTIQ misled investors by failing to accurately disclose material information about delayed sales at ZELTIQ and increased competition from a competitor's Liposonix business,” said shareholder rights attorney Willie Briscoe.
On March 6, 2012, shares of ZELTIQ plummeted after the company announced fourth quarter 2011 sales and profits that fell well below analyst estimates. For the quarter, ZELTIQ reported a loss per share of $0.22, while analysts had been expecting a per share loss of only $0.09. In addition, ZELTIQ predicted 2012 sales in the range of $90 million to $94 million, far below analyst expectations of $114 million.The Briscoe Law Firm, PLLC is a full service business litigation, commercial transaction, and public advocacy firm with more than 20 years of experience in complex litigation and transactional matters. Powers Taylor, LLP is a boutique litigation law firm that handles a variety of complex business litigation matters, including claims of investor and stockholder fraud, shareholder oppression, shareholder derivative suits, and security class actions.